Association of prescription abandonment with cost share for high-cost specialty pharmacy medications.

@article{Gleason2009AssociationOP,
  title={Association of prescription abandonment with cost share for high-cost specialty pharmacy medications.},
  author={P. Gleason and Catherine I Starner and Brent W Gunderson and Jeremy A Schafer and H Scott Sarran},
  journal={Journal of managed care pharmacy : JMCP},
  year={2009},
  volume={15 8},
  pages={648-58}
}
BACKGROUND In 2008, specialty medications accounted for 15.1% of total pharmacy benefit medication spending, and per member expenditures have increased by 11.1% annually from 2004 to 2008 within a commercially insured population of 8 million members. Insurers face increasing pressure to control specialty medication expenditures and to rely on increasing member cost share through creation of a fourth copayment tier within the incentive-based formulary pharmacy benefit system. Data are needed on… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Characteristics of patients using specialty medications.

Research in social & administrative pharmacy : RSAP • 2018

Impact of Medicare Part D on Racial and Ethnic Minorities.

Diversity and equality in health and care • 2016

Association of Medication Persistency with Route of Administration and Patient Cost-Sharing: Analysis of Commonly Used Biologics.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research • 2015

References

Publications referenced by this paper.
Showing 1-10 of 12 references

Rheumatoid arthritis

Arthritis Foundation
Available at: http://www. arthritis.org/disease-center.php?disease_id=31. Accessed October • 2009

Connect and create value : 2009 drug trend insights . July 17 , 2009

D Stern
J Manag Care Pharm • 2008

The promise of specialty pharmaceuticals: are they worth the price

SD Sullivan
J Manag Care Pharm. 2008;14(4):S3-S6. Available at: http://www.amcp • 2008

AARP Public Policy Institute. Rx watchdog report: trends in manufacturer prices of specialty prescription drugs used by Medicare beneficiaries

SW Schondelmeyer, L Purvis, DJ. Gross
Available at: http:// assets.aarp.org/rgcenter/health/2008_15_specialty_q407.pdf. Accessed October • 2004

Similar Papers

Loading similar papers…